Autologous morphogen gradients by subtle interstitial flow and matrix interactions

Biophysical Journal

Volumn 91, Issue 1, 2006, Pages 113-121

  Fleury, Mark E ^a   Boardman, Kendrick C ^b   Swartz, Melody A ^a,b  

^a EPFL   (Switzerland)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CHEMOTACTIC PEPTIDE; ENDOSTATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MATRIX PROTEIN; MORPHOGEN; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMIN; PROTEINASE; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASCULOTROPIN 165; VON WILLEBRAND FACTOR;

ARTICLE; CAPILLARY; CHEMOTAXIS; DYNAMICS; FLOW MEASUREMENT; IMMUNOCOMPETENT CELL; INTERSTITIUM; LYMPHATIC DRAINAGE; MORPHOGENESIS; PHAGOCYTOSIS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SECRETION; THERMODYNAMICS; TUMOR CELL;

EID: 33745762953     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.105.080192     Document Type: Article

References (57)

1. Gurdon, J. B., and P. Y. Bourillot. 2001. Morphogen gradient interpretation. Nature. 413:797-803.
2. Ruhrberg, C., H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, H. Fujisawa, C. Betsholtz, and D. T. Shima. 2002. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16:2684-2698.
3. Manes, S., C. Gomez-Mouton, R. A. Lacalle, S. Jimenez-Baranda, E. Mira, and C. Martinez-A. 2005. Mastering time and space: immune cell polarization and chemotaxis. Semin. Immunol. 17:77-86.
4. Zigmond, S. H. 1977. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. 75:606-616.
5. Turing, A. M. 1952. The chemical basis of morphogenesis. Philos. Trans. R. Soc. Lond. B. 237:37-72.
6. Park, J. E., G. A. Keller, and N. Ferrara. 1993. Vascular Endothelial growth-factor (VEGF) isoforms. Differential deposition into the subepithelial extracellular-matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell. 4:1317-1326.
7. Patel, D. D., W. Koopmann, T. Imai, L. P. Whichard, O. Yoshie, and M. S. Krangel. 2001. Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99:43-52.
8. Sahni, A., M. Guo, S. K. Sahni, and C. W. Francis. 2004. Interleukin-1 β but not IL-1 α binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood. 104:409-414.
9. Sahni, A., T. Odrljin, and C. W. Francis. 1998. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem. 273:7554-7559.
10. Houck, K. A., D. W. Leung, A. M. Rowland, J. Winer, and N. Ferrara. 1992. Dual regulation of vascular endothelial growth-factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:26031-26037.
11. Lee, S., S. M. Jilani, G. V. Nikolova, D. Carpizo, and M. L. Iruela-Arispe. 2005. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169:681-691.
12. Hall, H., T. Baechi, and J. A. Hubbell. 2001. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc. Res. 62:315-326.
13. Zisch, A. H., U. Schenk, J. C. Schense, S. E. Sakiyama-Elbert, and J. A. Hubbell. 2001. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Controlled Release. 72:101-113.
14. Levick, J. R. 1987. Flow through interstitium and other fibrous matrices. Q. J. Exp. Physiol. 72:409-437.
15. Renkin, E. M. 1986. Some consequences of capillary-permeability to macromolecules. Starlings hypothesis reconsidered. Am. J. Physiol. 250:H706-H710.
16. Chary, S. R., and R. K. Jain. 1989. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc. Natl. Acad. Sci. USA. 86:5385-5389.
17. Dafni, H., T. Israely, Z. M. Bhujwalla, L. E. Benjamin, and M. Neeman. 2002. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: Magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res. 62:6731-6739.
18. Jain, R. K. 1999. Transport of molecules, particles, and cells in solid tumors. Ann. Rev. Biomed. Eng. 1:241-263.
19. Leu, A. J., D. A. Berk, F. Yuan, and R. K. Jain. 1994. Flow velocity in the superficial lymphatic network of the mouse tail. Am. J. Physiol. 36:H1507-H1513.
20. Ng, C. P., C. L. E. Helm, and M. A. Swartz. 2004. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68:258-264.
21. Helm, C. L. E., M. E. Fleury, A. H. Zisch, F. Boschetti, and M. A. Swartz. 2005. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. USA. 102:15779-15784.
22. Semino, C. E., R. D. Kamm, and D. A. Lauffenburger. 2006. Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Exp. Cell Res. 312:289-298.
23. Hosseinkhani, H., Y. Inatsugu, Y. Hiraoka, S. Inoue, and Y. Tabata. 2005. Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic acid) fiber. Tissue Eng. 11:1476-1488.
24. Brinkman, H. C. 1947. A calculation of the viscous force exerted by a flowing fluid on a dense swarm of particles. Appl. Sci. Res. Sect. A. Mech. 1:27-34.
25. Barman, B. 1996. Flow of a Newtonian fluid past an impervious sphere embedded in a porous medium. Indian J. Pure Appl. Math. 27:1249-1256.
26. Anand, S., J.-H. Wu, and S. L. Diamond. 1995. Enzyme-mediated proteolysis of fibrous biopolymers: dissolution front movement in fibrin or collagen under conditions of diffusive or convective transport. Biotechnol. Bioeng. 48:89-107.
27. Ng, C. P., and M. A. Swartz. 2003. Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. Am. J. Physiol. 284:H1771-H1777.
28. Berk, D. A., F. Yuan, M. Leunig, and R. K. Jain. 1993. Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. Biophys. J. 65:2428-2436.
29. Berk, D. A., F. Yuan, M. Leunig, and R. K. Jain. 1997. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc. Natl. Acad. Sci. USA. 94:1785-1790.
30. Pluen, A., P. A. Netti, R. K. Jain, and D. A. Berk. 1999. Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys. J. 77:542-552 [comment].
31. Ramanujan, S., A. Pluen, T. D. McKee, E. B. Brown, Y. Boucher, and R. K. Jain. 2002. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys. J. 83:1650-1660.
32. Raeber, G. P., M. P. Lutolf, and J. A. Hubbell. 2005. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys. J. 89:1374-1388.
33. Wolf, K., I. Mazo, H. Leung, K. Engelke, U. H. von Andrian, E. I. Deryugina, A. Y. Strongin, E. B. Brocker, and P. Friedl. 2003. Compensation mechanism in tumor cell migration: mesenchymalamoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160:267-277.
34. Stokes, C. L., D. A. Lauffenburger, and S. K. Williams. 1991. Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J. Cell Sci. 99:419-430.
35. Sternlicht, M. D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
36. Tong, S., and F. Yuan. 2001. Numerical simulations of angiogenesis in the cornea. Microvasc. Res. 61:14-27.
37. Mac Gabhann, F., and A. S. Popel. 2005. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. Am. J. Physiol. 288:H2851-H2860.
38. Schneider, I. C., and J. M. Haugh. 2005. Quantitative elucidation of a distinct spatial gradient-sensing mechanism in fibroblasts. J. Cell Biol. 171:883-892.
39. Devreotes, P., and C. Janetopoulos. 2003. Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J. Biol. Chem. 278:20445-20448.
40. Nonaka, S., Y. Tanaka, Y. Okada, S. Takeda, A. Harada, Y. Kanai, M. Kido, and N. Hirokawa. 1998. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell. 95:829-837.
41. Boardman, K. C., and M. A. Swartz. 2003. Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92:801-808.
42. Kholodenko, B. 2006. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 7:165-176.
43. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev.Immunol. 5:617-628.
44. Stacker, S. A., M. G. Achen, L. Jussila, M. E. Baldwin, and K. Alitalo. 2002. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer. 2:573-583.
45. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:23-33.
46. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T. Blankenstein, G. Henning, and R. Forster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 21:279-288.
47. Reference deleted in proof.
48. Kodama, M., M. Naito, H. Nomura, A. Iguchi, W. D. Thompson, C. M. Stirk, and E. B. Smith. 2002. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels. Life Sci. 71:1139-1148.
49. Naito, M., C. M. Stirk, E. B. Smith, and W. D. Thompson. 2000. Smooth muscle cell outgrowth stimulated by fibrin degradation products: the potential role of fibrin fragment E in restenosis and atherogenesis. Thromb. Res. 98:165-174.
50. Klebe, R. J. 1988. Cytoscribing: a method for micropositioning cells and the construction of two-dimensional and 3-dimensional synthetic tissues. Exp. Cell Res. 179:362-373.
51. Nahmias, Y., R. E. Schwartz, C. M. Verfaillie, and D. J. Odde. 2005. Laser-guided direct writing for three-dimensional tissue engineering. Biotechnol. Bioeng. 92:129-136.
52. Alp, B., G. M. Stephens, and G. H. Markx. 2002. Formation of artificial, structured microbial consortia (ASMC) by dielectrophoresis. Enzyme Microb. Technol. 31:35-43.
53. Sahni, A., S. K. Sahni, P. J. Simpson-Haidaris, and C. W. Francis. 2004. Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J. Thromb. Haemost. 2:1629-1636.
54. Keuren, J. F. W., D. Baruch, P. Legendre, C. V. Denis, P. J. Lenting, J. P. Girma, and T. Lindhout. 2004. Von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate. Blood. 103:1741-1746.
55. Sadler, J. E. 1998. Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 67:395-424.
56. Reis, R. C. M., D. Schuppan, A. C. Barreto, M. Bauer, J. P. Bork, G. Hassler, and T. Coelho-Sampaio. 2005. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem. Biophys. Res. Commun. 333:976-983.
57. Yasui, N., T. Mori, D. Morito, O. Matsushita, H. Kourai, K. Nagata, and T. Koide. 2003. Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. Biochemistry (Mosc.). 42:3160-3167.